BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 3064527)

  • 21. [Plasma exchange in progressive lupus nephritis].
    Hörmann A; Keusch G; Burger R; Briner J; Binswanger U; Gmür J
    Schweiz Med Wochenschr; 1982 Jun; 112(24):853-8. PubMed ID: 7112055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monthly plasmapheresis for systemic lupus erythematosus with diffuse proliferative glomerulonephritis: a pilot study.
    Clark WF; Lindsay RM; Cattran DC; Chodirker WB; Barnes CC; Linton AL
    Can Med Assoc J; 1981 Jul; 125(2):171-4. PubMed ID: 7272867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The application of plasmapheresis in systemic lupus erythematosus.
    Jones JV
    Prog Clin Biol Res; 1982; 106():81-9. PubMed ID: 6817336
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cyclosporin therapy of patients with systemic lupus erythematosus].
    Gergely P
    Orv Hetil; 1994 Nov; 135(47):2591-5. PubMed ID: 7824258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological studies in systemic lupus erythematosus.
    Jin OC; Jacob E; Chua D; Lan YS; Hsii FP
    J Med Assoc Thai; 1978 Jan; 61 Suppl 1():10-7. PubMed ID: 304878
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapeutic plasmapheresis in systemic lupus erythematosus].
    Cui HL; Ma L; Zhu RQ
    Zhonghua Nei Ke Za Zhi; 1990 Jul; 29(7):422-4, 445. PubMed ID: 2282874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunosuppressive and immunomodulator treatment of severe systemic lupus].
    Guillevin L
    Ann Med Interne (Paris); 1996; 147(7):498-505. PubMed ID: 9092361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Aggressive therapy of highly active systemic lupus erythematosus].
    Graninger W
    Acta Med Austriaca; 1996; 23(4):129-33. PubMed ID: 9036724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Corticotherapy and plasma exchange in systemic lupus erythematosus].
    Rahbar K; Belghiti D; Sobel A
    Ann Med Interne (Paris); 1986; 137 Suppl():41-8. PubMed ID: 3545007
    [No Abstract]   [Full Text] [Related]  

  • 31. Cyclosporin A and therapeutic plasma exchange in the treatment of severe systemic lupus erythematosus.
    Bambauer R; Schwarze U; Schiel R
    Artif Organs; 2000 Nov; 24(11):852-6. PubMed ID: 11119071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of anti-DNA antibody and selected laboratory studies in systemic lupus erythematosus.
    Ludivico CL; Zweiman B; Myers AR; Hebert J; Green PA
    J Rheumatol; 1980; 7(6):843-9. PubMed ID: 6970815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus.
    Neuwelt CM; Lacks S; Kaye BR; Ellman JB; Borenstein DG
    Am J Med; 1995 Jan; 98(1):32-41. PubMed ID: 7825616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
    Petri M; Jones RJ; Brodsky RA
    Arthritis Rheum; 2003 Jan; 48(1):166-73. PubMed ID: 12528116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of remission in severe SLE after plasma exchange synchronized with subsequent pulse cyclophosphamide.
    Euler HH; Gutschmidt HJ; Schmuecking M; Schroeder JO; Loffler H
    Prog Clin Biol Res; 1990; 337():319-20. PubMed ID: 2191324
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intravenous administration of immunoglobulins in systemic lupus erythematosus: review of the literature and initial clinical experiences].
    Pirner K; Rubbert A; Burmester GR; Kalden JR; Manger B
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():131-5; discussion 136. PubMed ID: 8499742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lupus vasculitis].
    Kahn MF; Piette JC; Bourgeois P
    Recenti Prog Med; 1988; 79(7-8):323-9. PubMed ID: 3201028
    [No Abstract]   [Full Text] [Related]  

  • 39. Short and longterm experience with plasmapheresis in connective tissue diseases.
    Dequeker J; Geusens P; Wielands L
    Biomedicine; 1980 Dec; 32(4):189-94. PubMed ID: 7470581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.